HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Dina Halegoua-DeMarzio Selected Research
Dina Halegoua-DeMarzio Research Topics
Disease
8
Non-alcoholic Fatty Liver Disease
09/2023 - 11/2019
7
Fibrosis (Cirrhosis)
02/2024 - 12/2019
4
Neoplasms (Cancer)
06/2024 - 01/2021
3
Hepatocellular Carcinoma (Hepatoma)
06/2024 - 01/2022
3
Inflammation (Inflammations)
02/2024 - 11/2019
2
Chemical and Drug Induced Liver Injury
02/2024 - 01/2023
2
Liver Cirrhosis (Hepatic Cirrhosis)
10/2022 - 12/2019
1
Neoplasm Metastasis (Metastasis)
06/2024
1
Disease Progression
06/2024
1
Acute Liver Failure (Fulminant Hepatic Failure)
02/2024
1
Infections
02/2024
1
Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2024
1
Hemorrhage
11/2023
1
Inborn Genetic Diseases (Disease, Hereditary)
11/2023
1
Varicose Veins (Varicose Vein)
11/2023
1
Brain Diseases (Brain Disorder)
11/2023
1
Hyperplasia
11/2023
1
Hypertrophy
11/2023
1
Ascites
09/2023
1
Esophageal Achalasia (Megaesophagus)
09/2023
1
Esophageal and Gastric Varices (Esophageal Varices)
09/2023
1
Deglutition Disorders (Dysphagia)
09/2023
1
Portal Hypertension
09/2023
1
Weight Loss (Weight Reduction)
09/2023
1
Malnutrition (Nutritional Deficiencies)
09/2023
1
Sarcopenia
09/2023
1
Coronary Artery Disease (Coronary Atherosclerosis)
03/2021
1
Carcinoma (Carcinomatosis)
01/2021
1
Hyperlipidemias (Hyperlipidemia)
01/2021
1
Hypertension (High Blood Pressure)
01/2021
1
Obesity
01/2021
1
Nausea
12/2019
1
Alcoholic Fatty Liver
12/2019
1
Type 2 Diabetes Mellitus (MODY)
12/2019
1
Endotoxemia
11/2019
1
Dysbiosis
11/2019
Drug/Important Bio-Agent (IBA)
3
Protons (Proton)
IBA
01/2023 - 12/2019
2
alpha-Fetoproteins (alpha-Fetoprotein)
IBA
06/2024 - 01/2022
2
Dyphylline (Diprophylline)
FDA Link
02/2024 - 01/2023
2
Biomarkers (Surrogate Marker)
IBA
04/2023 - 10/2022
2
Pegbelfermin
IBA
04/2023 - 12/2019
2
Hemoglobins (Hemoglobin)
IBA
03/2021 - 01/2021
1
lenvatinib
IBA
06/2024
1
Bevacizumab (Avastin)
FDA Link
06/2024
1
atezolizumab
IBA
06/2024
1
Tyrosine Kinase Inhibitors
IBA
06/2024
1
Gemcitabine
FDA Link
06/2024
1
Oxaliplatin (Eloxatin)
FDA Link
Generic
06/2024
1
Amiodarone (Amiodarona)
FDA Link
Generic
02/2024
1
Circular DNA
IBA
02/2024
1
Ursodeoxycholic Acid (Urso)
FDA Link
Generic
01/2024
1
obeticholic acid
IBA
01/2024
1
Glucagon (Glukagon)
FDA Link
11/2023
1
Ammonia
IBA
11/2023
1
DNA (Deoxyribonucleic Acid)
IBA
04/2023
1
HLA Antigens (Human Leukocyte Antigens)
IBA
01/2023
1
Calcium
IBA
03/2021
1
Lipids
IBA
03/2021
1
F 4 (F-4)
IBA
03/2021
1
Enzymes
IBA
01/2021
1
Albumins
IBA
01/2021
1
fibroblast growth factor 21
IBA
12/2019
1
Branched-Chain Amino Acids
IBA
11/2019
1
Aromatic Amino Acids (Aromatic Amino Acid)
IBA
11/2019
1
Volatile Fatty Acids
IBA
11/2019
1
Cytokines
IBA
11/2019
1
Therapeutic Uses
IBA
11/2019
1
Bile Acids and Salts (Bile Acids)
IBA
11/2019
1
Ethanol (Ethyl Alcohol)
IBA
11/2019
1
Choline (Choline Chloride)
IBA
11/2019
1
Transaminases (Aminotransferases)
IBA
11/2019
Therapy/Procedure
4
Therapeutics
06/2024 - 09/2023
3
Liver Transplantation
02/2024 - 09/2023
2
Drug Therapy (Chemotherapy)
06/2024 - 01/2024
1
Hyperthermic Intraperitoneal Chemotherapy
06/2024
1
Cytoreduction Surgical Procedures
06/2024
1
Immunotherapy
06/2024
1
Contraindications
09/2023
1
Myotomy
09/2023
1
Surgical Portasystemic Shunt (Portosystemic Shunt)
09/2023
1
Aftercare (After-Treatment)
04/2023
1
Pancreaticoduodenectomy
01/2021
1
Length of Stay
01/2021
1
Subcutaneous Injections
12/2019